C diff Infection News from Send2Press Newswire

C diff Infection News

News items related to C diff Infection as issued by the Send2Press Newswire service on behalf of the noted news source.

Leading Healthcare-Associated Infection Clostridioides difficile Symposium Focuses on Patients, Families, and Caregivers

Thu, 19 Nov 2020, 06:45:48 EST | From: C Diff Foundation

TAMPA, Fla., Nov. 19, 2020 (SEND2PRESS NEWSWIRE) — C Diff Foundation announced today that the Inaugural Patient, Family, and Caregiver C. diff. Live Virtual Symposium will be hosted on November 23, 2020 at 1 p.m.-4 p.m. EST with keynote topic-experts dedicated in disciplines of healthcare, pharma, biotech, and academia. The event is complimentary with online registration.

2020 International Clostridioides difficile (C. diff., C. difficile) Virtual Conference and Health EXPO Nov. 14

Wed, 11 Nov 2020, 06:45:34 EST | From: C Diff Foundation

TAMPA, Fla., Nov. 11, 2020 (SEND2PRESS NEWSWIRE) — C Diff Foundation announced today that the 8th Annual International C. diff. Virtual-Online Conference and Health EXPO will be a 5-1/2 hour online program with over fourteen international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies.

Progenabiome Shares New Data on Fecal Transplant, Sars-Cov-2 at ACG 2020

Mon, 26 Oct 2020, 14:58:16 EDT | From: ProgenaBiome

VENTURA, Calif., Oct. 26, 2020 (SEND2PRESS NEWSWIRE) — The American College of Gastroenterology (ACG) named Progenabiome “Outstanding Poster Presenter” for its poster: “Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection,” which will be presented virtually at the ACG Annual Scientific Meeting this week.

Alzheimer’s Patient Recalls Daughter’s Birthday After Undergoing Fecal Transplant

Wed, 07 Oct 2020, 08:02:14 EDT | From: ProgenaBiome

VENTURA, Calif., Oct. 7, 2020 (SEND2PRESS NEWSWIRE) — Dr. Sabine Hazan, founder of ProgenaBiome, a genetic sequencing lab in California, achieved rapid improvement in Alzheimer’s disease (AD) symptoms in an 82-year-old male patient following fecal microbiota transplantation (FMT).